These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 15173844)

  • 1. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.
    D'Souza DC; Perry E; MacDougall L; Ammerman Y; Cooper T; Wu YT; Braley G; Gueorguieva R; Krystal JH
    Neuropsychopharmacology; 2004 Aug; 29(8):1558-72. PubMed ID: 15173844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
    D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
    Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
    Ranganathan M; Carbuto M; Braley G; Elander J; Perry E; Pittman B; Radhakrishnan R; Sewell RA; D'Souza DC
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1251-64. PubMed ID: 22243563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
    D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E
    Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.
    Morrison PD; Zois V; McKeown DA; Lee TD; Holt DW; Powell JF; Kapur S; Murray RM
    Psychol Med; 2009 Oct; 39(10):1607-16. PubMed ID: 19335936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
    D'Souza DC; Pittman B; Perry E; Simen A
    Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system effects of haloperidol on THC in healthy male volunteers.
    Liem-Moolenaar M; te Beek ET; de Kam ML; Franson KL; Kahn RS; Hijman R; Touw D; van Gerven JM
    J Psychopharmacol; 2010 Nov; 24(11):1697-708. PubMed ID: 20142302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC.
    Bhattacharyya S; Sainsbury T; Allen P; Nosarti C; Atakan Z; Giampietro V; Brammer M; McGuire PK
    Psychol Med; 2018 Dec; 48(16):2748-2756. PubMed ID: 29502548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
    Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC
    Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
    Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
    Koethe D; Gerth CW; Neatby MA; Haensel A; Thies M; Schneider U; Emrich HM; Klosterkötter J; Schultze-Lutter F; Leweke FM
    Schizophr Res; 2006 Dec; 88(1-3):142-50. PubMed ID: 17005373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
    Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
    Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
    Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cannabinoids on serum cortisol and prolactin in humans.
    Ranganathan M; Braley G; Pittman B; Cooper T; Perry E; Krystal J; D'Souza DC
    Psychopharmacology (Berl); 2009 May; 203(4):737-44. PubMed ID: 19083209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.